Advertisements

Carboxymethylcellulose

Quick links to important sections

Carboxymethylcellulose

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Carboxymethylcellulose

Quick Facts

Property Description
Active Ingredient Carboxymethylcellulose (Carmellose) or Sodium Carboxymethylcellulose
Form Ophthalmic Solution (Eye Drops), Gel, Tablet Excipient
Pharmacological Class Demulcent, Viscosity Modifier, Ophthalmic Lubricant
Common Use Surface Hydration/Lubrication or Bulk-forming Laxative
Origin Semi-synthetic (derived from natural cellulose)

What Type of Substance is Carboxymethylcellulose (Carmellose)?

Carboxymethylcellulose (CMC), also widely recognized as Carmellose, is a semi-synthetic polymer that is chemically modified from natural cellulose fibers to make it highly water-soluble and hydrophilic. It is classified as an anionic cellulose derivative. The structural modification is essential, as it imparts the unique ability to bind water and increase viscosity. The most common form of the active ingredient used in pharmaceutical preparations is Sodium Carboxymethylcellulose (NaCMC), noted for its ability to increase the viscosity of aqueous solutions. This property allows the medicine to physically thicken liquids, making them adhere better to surfaces.


Pharmacological Class and Primary Forms of Carboxymethylcellulose

CMC primarily falls within the pharmacological classes of Demulcents and Viscosity Modifiers. This high-level classification reflects its mechanism of action, which involves protecting and soothing irritated mucous membranes. Within non-prescription formulations, Carboxymethylcellulose functions as an Ophthalmic Lubricant. This indicates that the medicine has a primary role in stabilizing the moisture layer on the eye's surface. The substance is formulated into multiple high-level dosage forms, including Ophthalmic solution (eye drops), Gel, and is commonly used as a non-active component (Excipient or Binder) in Tablets.


What is the General Purpose of Carboxymethylcellulose?

The general purpose of Carboxymethylcellulose is to provide mechanical relief, which differs based on the route of administration. When applied topically (ophthalmic route), the substance’s mucoadhesive property allows it to create a protective, hydrating layer, thereby relieving conditions associated with surface dryness. When the same hydrophilic polymer is ingested (oral route), its purpose shifts to physical modification: it absorbs water in the gut, adding bulk and increasing the overall volume of intestinal contents, which in turn assists with natural intestinal movement.

Advertisements

What side effects are possible with Carboxymethylcellulose?

Possible side effects and safety information

The official safety profile for Carboxymethylcellulose (CMC) is primarily characterized by adverse reactions that are local and generally non-systemic, consistent with its physical mechanism of action. Reactions are classified according to the organ system affected and the route of administration.


Adverse Reaction Scope and Classification

System-Organ Class Common Adverse Reactions
Eye Disorders (Ophthalmic Use) Eye irritation (stinging, burning, discomfort), Eye pain, Visual disturbance, Foreign body sensation.
Gastrointestinal Disorders (Oral Use) Abdominal cramps, Bloating, Flatulence (gas).

Adverse reactions associated with ophthalmic use, such as temporary blurred vision and minor stinging, are often described in regulatory documents as transient effects that occur immediately upon initial instillation. These local effects are typically categorized as Common.


Serious Reactions and Safety Constraints

The most significant safety constraint officially documented is the potential for Hypersensitivity Reactions (classified under Immune System Disorders), which are rare but serious events documented in regulatory post-marketing experience. These include severe reactions such as eye or eyelid swelling and represent the primary circumstance requiring immediate discontinuation of the product.

A known hypersensitivity to Carboxymethylcellulose or any component of the formulation is the only absolute contraindication listed in official labeling. Due to negligible systemic absorption, specific population-based restrictions for older adults or those with organ impairment are not typically noted in primary regulatory documents, although advice is given to wait for vision to clear before driving or operating machinery after instillation.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Carboxymethylcellulose overdose is structured by its negligible systemic risk from intended use. Overdose from excessive ophthalmic solution application is not anticipated to cause systemic toxicity, as the polymer is inert and not absorbed. Effects are typically localized, such as transient irritation or excessive tearing.

The primary concern is accidental oral ingestion of the product. Due to its bulk-forming properties, high-volume oral exposure may pose a risk for gastrointestinal obstruction. Furthermore, regulatory agencies note that accidental ingestion by children has been associated with serious adverse events.

Official guidance mandates immediate medical attention for any suspected overdose or accidental ingestion, requiring individuals to call a Poison Control Center right away. Urgent help is required if ingestion results in life-threatening symptoms, such as passing out or trouble breathing, at which point emergency services must be contacted immediately. Management, lacking a specific antidote, is defined by regulatory documents as symptomatic and supportive treatment.

Advertisements

Therapeutic Uses of Carboxymethylcellulose

What Carboxymethylcellulose Treats: Main Uses and Benefits

Carboxymethylcellulose (CMC) is an ophthalmic lubricant commonly used across conditions presenting with acute episodes of dryness and is relevant when supportive symptom management is appropriate. Its primary role is for the temporary relief of symptoms related to physical discomfort and irritation in the eyes.

The use of this substance is relevant for easing symptoms linked to organ-specific functional stress. CMC is applied in addressing dry eye syndrome symptoms such as burning, irritation, and discomfort. These symptoms that interfere with daily functioning are often seen in clinical scenarios involving temporary physiological imbalance or exposure to environmental factors like wind and sun.

This application assists with maintaining functional stability and contributes to easing the overall symptom load. This product supports patients during episodes of heightened discomfort.

“This application may assist with providing supportive relief when symptoms interfere with routine activities.”

Quick Fact: Relief for Irritation and Dryness

Regulatory References

  1. NIH DailyMed Product Label
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Carboxymethylcellulose — official regulatory information


Eligibility Scope

Classification Population or Condition Regulatory Status
Contraindicated Patients with known hypersensitivity to carmellose sodium or any excipients. Must not use
Established Use Adults, including the older adult population. Use is established
Not Recommended Children and adolescents (pediatric population). Use is not established
Conditional Use Pregnancy and breastfeeding. Generally permitted (negligible systemic exposure)

Official Eligibility Rules

Populations for whom use is allowed: Use is established for adults, including the older adult population, as documented in the official prescribing information.

Populations for whom use is contraindicated: Use is contraindicated in patients with a known hypersensitivity or allergy to the active substance, carmellose sodium, or any other component of the formulation.

Age-related eligibility rules: Use is not established and officially not recommended for the pediatric population due to the absence of specific clinical safety and efficacy data.

Physiological eligibility status: Use is generally permitted during pregnancy and breastfeeding due to the medicine's negligible systemic absorption. No formal eligibility restrictions exist based on renal or hepatic impairment.


Connection to the Overall Eligibility Profile

Regulatory documents define who can and cannot use the medicine based primarily on the absolute exclusion criteria for a known allergy to the formulation components. Use is established for the adult population, but it is classified as not established and not recommended for the pediatric age group due to the absence of specific clinical safety data. Systemic conditions do not result in formal exclusions because the medicine is documented as having negligible systemic absorption.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

The official interaction profile for Carboxymethylcellulose (CMC) is primarily defined by physical constraints rather than systemic metabolic activity. This is due to the negligible systemic absorption observed after either topical ophthalmic or oral administration.

Category Regulatory-Documented Statement
Systemic Interactions (Metabolic/CYP) None documented. No cytochrome P450 (CYP) mediated or transporter-based interactions are anticipated or documented in regulatory labeling for the ophthalmic form.
Exposure-Modifying Substances Other Topical Ophthalmic Products (Local Exposure Decrease). Co-administration may cause physical displacement or interfere with the local ocular absorption of concurrently applied eye medications.

Timing and Administration Constraints

The primary concern documented in regulatory labeling involves timing-based interaction rules to manage local physical interference. If co-administering Carboxymethylcellulose with other topical ophthalmic medicinal products, a mandatory separation time of at least 5 to 15 minutes must be observed between instillations. The administration sequence is also constrained: the most viscous product or topical eye ointments must be administered last to minimize the physical displacement of the other medication.

For the oral, bulk-forming class of Carboxymethylcellulose, an interaction warning exists regarding the potential for decreased systemic absorption of other simultaneously administered oral medicinal products, necessitating dose separation.

Advertisements

Mechanism of Action

Carboxymethylcellulose (CMC) is a high-molecular-weight, water-soluble polymer that exerts its effects through two primary mechanistic domains: Viscosity and Mucoadhesion and Molecular Cell Signaling.


Viscosity and Mucoadhesion

CMC possesses an anionic charge, which, upon application, causes it to increase the viscosity of the local fluid. This physical property enables mucoadhesion, where the polymer chains bind to the mucosal surface. The resultant physiological consequence is the prolongation of the film's retention time on the epithelial surface, regulating local fluid dynamics.


Molecular Cell Signaling

This domain involves specific molecular interactions. The glucopyranose subunits of CMC bind to cell-surface receptors, including GLUT-1, found on epithelial cells. This interaction initiates or modifies signaling sequences that influence cellular processes such as epithelial cell attachment, migration, and re-epithelialization. This pathway modulation affects downstream signaling that regulates epithelial cellular integrity.

Advertisements

Dosage and Administration Information

Carboxymethylcellulose ophthalmic solution is an eye lubricant administered via the ophthalmic route.

Official Administration Guidelines

Administration Scope Details
Route of Administration Ophthalmic (for external use in the eye only).
Dosing Schedule Instill 1 or 2 drops in the affected eye(s) as needed, or up to 4 times a day for some multi-dose formulations.
Timing in Relation to Meals Not applicable; use does not depend on food timing.
Preparation Requirements For single-use containers, TWIST AND PULL TAB TO REMOVE to open. Some multi-dose bottles may require the cap to be tightened to pierce the tip. Do not use if the solution changes color or becomes cloudy.
Age-Group Rules If used for post-operative dryness (e.g., LASIK), follow the instructions provided by an eye doctor. For children under 6 years of age, consult a doctor.
Missed-Dose Rules If using regularly and a dose is missed, apply a single drop as soon as remembered. If it is close to the time for the next dose, skip the missed dose and resume the regular schedule. Do not use two doses to make up for a missed one.
Special Procedural Conditions Wash your hands before use. Do not touch the tip of the container to any surface, including the eye or eyelid, to avoid contamination. If using other eye medicines, allow an interval of at least 5 to 15 minutes between applications, and use eye drops before ointments. Single-use containers must be discarded immediately after instillation and not reused.

Resulting Procedural Structure (Key Steps)

  • Wash your hands thoroughly.
  • Open the container as instructed (e.g., twist and pull the tab).
  • Tilt the head back and pull down the lower eyelid to create a pouch.
  • Instill 1 or 2 drops into the affected eye(s).
  • Close the eye and apply gentle pressure to the inner corner of the eye near the nose for 1 to 2 minutes to keep the drug in the eye.
  • Discard the single-use container or replace the cap tightly for multi-dose bottles.

The administration of Carboxymethylcellulose is a precise, topical ophthalmic procedure designed for as-needed or routine application, typically one to four times daily, based on specific product instructions. The official instructions focus on strict contamination control, proper instillation technique, and adherence to dosing frequency for safe and effective use.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Carboxymethylcellulose


Evidence for Temporary Relief of Dry Eye Symptoms

CMC has been studied for use in eye care, particularly in research exploring conditions marked by functional limitations, such as dry eye symptoms. Studies exploring short-term symptom changes have utilized rigorous methods, including Randomized Controlled Trials (RCTs), where CMC solutions were evaluated against a placebo or other lubricants. These studies were conducted during periods of increased symptom activity to understand how symptoms change over a defined time interval.

The research examined various patient-reported outcomes related to physical discomfort and daily functioning. Primary outcomes included ratings of perceived discomfort, burning, and irritation, typically measured using standardized scales. Researchers also monitored objective measures, such as the Tear Break-Up Time (TBUT) and the degree of ocular surface staining. Studies describe patterns observed in these subjective and objective measures during the short-term observation periods. Regulatory documentation describes the substance as a demulcent and ophthalmic lubricant.


Research on its Bulk-Forming Properties (Oral Use)

The evidence base for Carboxymethylcellulose as an agent for bulk-forming support differs significantly from its ophthalmic use. Research in this area primarily involves non-clinical studies using animal models and detailed Toxicological and Safety Evaluations. These studies have explored the physical properties of CMC as a water-soluble polymer in the digestive tract. Non-clinical data describes patterns associated with water retention and fecal bulk. This type of research provides context on the substance's properties but does not rely on the same level of dedicated human clinical trials as the ophthalmic applications.


Long-Term Studies and Follow-up Durations

Research on Carboxymethylcellulose for both its primary uses generally emphasizes short-term symptom patterns. Most clinical trials conducted for the ophthalmic solutions focus on periods lasting between one week and three months, establishing its relevance in trials assessing short-term or episodic symptom patterns. Consequently, long-term effects are not fully established, and there is limited information for long-term outcomes associated with continued use beyond this intermediate-term window.


What is Still Uncertain About Carboxymethylcellulose Research

Regarding its ophthalmic use, evidence has explored outcomes related to acute and episodic dry eye symptoms, but comparative evidence is lacking in trials against other existing treatments. For its oral bulk-forming property, certainty remains low regarding patient outcomes for human functional constipation because the evidence quality varies across studies, and there is an absence of dedicated, high-quality Randomized Controlled Trials.

Key Studies & References

  1. Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease
  2. Label: CARBOXYMETHYLCELLULOSE SODIUM solution/ drops (FDA DailyMed - OTC Monograph Drug M018)
  3. FDA OTC Drug Monograph - Ophthalmic Drug Products for Over-the-Counter Human Use (M018, Part 349)
  4. Laxatives: Bulk Forming - Labelling Standards (Health Canada)
  5. Assessing the Effects of 0.3% Carboxymethylcellulose Tear Substitute Treatment on Symptoms and Signs of Dry Eye Disease in Elderly Population: A Prospective Longitudinal Study
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Carboxymethylcellulose (FAQ)


Q: How long does the relief from Carboxymethylcellulose usually last?

The active substance is a high-viscosity polymer that is described in official documents as binding to the eye’s surface. This process, known as mucoadhesion, works to prolong the medicine’s retention time on the ocular surface. Official information indicates this mechanism of action extends the moisturizing and comforting effect on the eye.


Q: Is Carboxymethylcellulose an over-the-counter medicine?

Many formulations of Carboxymethylcellulose ophthalmic solution are regulated as Over-The-Counter (OTC) Human Drug Products. These products are intended for the temporary relief of dry eye symptoms and are commonly available without a prescription.


Q: Will Carboxymethylcellulose help with eye redness and irritation?

Official labeling states the product is indicated for the temporary relief of burning, irritation, and discomfort due to eye dryness. However, relief from eye redness is not explicitly listed as a primary indication for its use.


Q: Is Carboxymethylcellulose safe to use with glaucoma medication?

Since Carboxymethylcellulose is a topical eye medication with negligible systemic absorption, it is not expected to cause internal drug-drug interactions. Regulatory documents require a time interval of at least 15 minutes between instilling this product and any other ocular medicine to prevent physical interference.


Q: What is the maximum duration of continuous use mentioned in official documents?

Official safety warnings indicate that if symptoms persist or worsen, discontinuation of use and immediate consultation with a healthcare professional is indicated. Specifically, official guidance recommends consulting a healthcare provider if eye pain, changes in vision, continued redness, or irritation occurs for more than 72 hours.


Q: Does Carboxymethylcellulose contain any preservatives?

Carboxymethylcellulose products are available in two main formats: multi-dose bottles, which often contain preservatives, and single-use vials, which are typically preservative-free. The list of inactive ingredients, including any preservatives, can be found in the product’s official labeling.


Q: Is Carboxymethylcellulose the same thing as methylcellulose?

Carboxymethylcellulose is chemically described as a distinct derivative of cellulose. While both are cellulose derivatives used for ophthalmic lubrication, official regulatory standards list them separately as distinct active ingredients.


Q: Does Carboxymethylcellulose interact with contact lens solutions?

The interaction profile is primarily physical. Some formulations contain preservatives that have the potential to discolor or damage soft contact lenses. Product packaging should be reviewed, and information about concurrent use may be obtained from an eye care professional.


Q: Is there a generic version of Carboxymethylcellulose available?

Yes, the product is widely available. The active substance, Carboxymethylcellulose sodium solution, is found in many generic or store-brand products, in addition to various branded options.


Q: Can Carboxymethylcellulose be used while wearing contact lenses?

Preservative-free formulations are generally permitted for use while wearing soft contact lenses. However, multi-dose products containing preservatives usually require lenses to be removed before instillation, with a short waiting period before replacement, as noted in the official instructions.


Q: What happens if I accidentally use too much Carboxymethylcellulose at once?

Official safety documents state that accidental overdose or consumption is not expected to present a hazard. This is due to the product's negligible absorption into the bloodstream and its low toxicity profile.


Q: What are the inactive ingredients usually found in Carboxymethylcellulose products?

Common inactive ingredients often include salts that mimic the electrolyte balance of natural tears, such as sodium and potassium chloride. These are combined with purified water and sometimes buffering agents to ensure the solution is comfortable for the eye.


Q: How quickly should I expect to feel the effect of Carboxymethylcellulose?

The product is designed to provide immediate lubrication and comfort upon contact with the eye surface. If temporary blurred vision occurs right after use, it serves as a common indication that the product is coating the eye surface and beginning its action.


Q: Does Carboxymethylcellulose help with night-time dry eyes?

The product is indicated for general relief of dry eye symptoms. Some formulations, particularly those with a gel or higher viscosity, are described as being applied just before bed for sustained night-time relief. Specific instructions for use should be followed based on the product type.


Q: Can I share my Carboxymethylcellulose drops with someone else?

Official regulatory warnings stress the importance of contamination control. To avoid the risk of spreading eye infections, it is explicitly noted that each multi-dose container should be used by only one person.


Q: Is Carboxymethylcellulose suitable for people with sensitive eyes?

Some formulations are marketed as preservative-free and may be described as being suitable for people with sensitive eyes, aiming to reduce irritation from excipients. However, eye irritation is still listed as a common, transient side effect in official safety documents.


Q: Can people with diabetes safely use Carboxymethylcellulose?

Official information indicates that Carboxymethylcellulose has negligible absorption into the bloodstream. Therefore, it is not expected to interfere with systemic conditions such as diabetes, and no special warnings or dosage adjustments are listed for this population.


Q: Is it okay to use Carboxymethylcellulose if I have an eye infection?

If you are experiencing symptoms like eye pain, changes in vision, or worsening redness or irritation, discontinuation of use and immediate consultation with a healthcare professional is indicated. Official warnings indicate these symptoms may signal a developing infection or other serious condition.


Q: Does Carboxymethylcellulose act as a shield against environmental irritants?

Yes, official labeling indicates that the product may be used as a protectant against further irritation. This protective action includes mitigating irritation caused by exposure to environmental factors such as wind or sun.


Q: Is there a link between Carboxymethylcellulose and headaches?

Headaches are not listed among the common or uncommon adverse reactions reported for the ophthalmic solution in official safety documents. Adverse effects are typically localized to the eye.


Q: Can Carboxymethylcellulose be used for contact lens comfort drops?

Some specific preservative-free formulations are designed to be used while wearing contact lenses to enhance comfort and lubrication. Use with other formulations generally requires lens removal before instillation, as noted in the official instructions.


Q: Does Carboxymethylcellulose dissolve easily in the tear film?

The product is classified as a water-soluble polymer and is designed to mix easily with the natural tear film. This combination forms a protective, viscous layer that works to prolong its retention time on the eye surface.


Q: How does the concentration of Carboxymethylcellulose affect its action?

Carboxymethylcellulose solutions are available in different concentrations, such as 0.5% and 1%. Official information indicates that these variations directly relate to the solution's viscosity and the duration of the moisturizing and lubricating effect on the eye surface.

Advertisements

How should Carboxymethylcellulose be stored and disposed of?

Storage and Disposal Requirements for Carboxymethylcellulose

Carboxymethylcellulose ophthalmic solution must be stored strictly according to regulatory labeling to maintain product stability and safety.

Storage Conditions

The medicine should be stored at controlled room temperature, typically between 15 C and 30 C (59 F to 86 F), and must not be frozen. Keep the container tightly closed and stored in its original packaging. For multi-dose bottles, the solution must be discarded 28 days after the date of first opening. Single-use vials should be discarded immediately after use. Crucially, the product must be kept out of the sight and reach of children.

Disposal

To dispose of unused or expired product, mix the contents with an undesirable substance, such as dirt or used coffee grounds, and place the mixture in a sealed container before discarding it in the household trash. Do not flush the solution down the toilet or pour it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Carboxymethylcellulose found in:

A-Z Index: